Drug delivery to the ear

Author:

Hoskison E12,Daniel M123,Al-Zahid S13,Shakesheff KM4,Bayston R35,Birchall JP6

Affiliation:

1. Department of Otorhinolaryngology, Head & Neck Surgery, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, UK

2. NIHR Nottingham Hearing Biomedical Research Unit, Nottingham, UK

3. Biomaterials-Related Infection Group, Division of Orthopaedic & Accident Surgery, University of Nottingham, UK

4. The Wolfson Centre for Stem Cells, Tissue Engineering & Modelling (STEM), The University of Nottingham, UK

5. Surgical Infection Head, Biomaterials-Related Infection Group, School of Clinical Sciences, Nottingham University Hospitals, UK

6. Department of Otorhinolaryngology, Head & Neck Surgery, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, UK.

Abstract

Drug delivery to the ear is used to treat conditions of the middle and inner ear such as acute and chronic otitis media, Ménière’s disease, sensorineural hearing loss and tinnitus. Drugs used include antibiotics, antifungals, steroids, local anesthetics and neuroprotective agents. A literature review was conducted searching Medline (1966–2012), Embase (1988–2012), the Cochrane Library and Ovid (1966–2012), using search terms ‘drug delivery’, ‘middle ear’, ‘inner ear’ and ‘transtympanic’. There are numerous methods of drug delivery to the middle ear, which can be categorized as topical, systemic (intravenous), transtympanic and via the Eustachian tube. Localized treatments to the ear have the advantages of targeted drug delivery allowing higher therapeutic doses and minimizing systemic side effects. The ideal scenario would be a carrier system that could cross the intact tympanic membrane loaded with drugs or biochemical agents for the treatment of middle and inner ear conditions.

Publisher

Future Science Ltd

Subject

Pharmaceutical Science

Reference64 articles.

Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3